Societal CDMO is a bi-coastal contract development and manufacturing organization (CDMO) with capabilities spanning pre-Investigational New Drug (IND) development to commercial manufacturing and packaging for a wide range of therapeutic dosage forms with a primary focus in the area of small molecules. With an expertise in solving complex manufacturing problems, Societal is a leading CDMO providing therapeutic development, end-to-end regulatory support, clinical and commercial manufacturing, aseptic fill/finish, lyophilization, packaging, and logistics services the global pharmaceutical market. 

In addition to our experience in handling DEA controlled substances and developing and manufacturing modified-release dosage forms, Societal CDMO has the expertise to deliver on our clients’ pharmaceutical development and manufacturing projects, regardless of complexity level. We do all of this in our best-in-class facilities, totaling 145,000 square feet, in Gainesville, Georgia, and San Diego, California.


Pharmaceutical

Therapeutics

Societal™ CDMO

J. David Enloe, Jr.

Carla Lusby

Matthew McKendry

Jennifer R.

Daphne Najarian

Tim Roach

Megha Nair

Julie Christian

Carol Bolger

Scott Rizzo

Richard Sidwell

The Scientific Research and Development team at Societal™ CDMO conducts cutting-edge research and innovation in the development of small molecule therapeutics. The team focuses on formulation, analytical development, and the creation of modified-release dosage forms, while also addressing complex manufacturing challenges. They provide critical support from pre-Investigational New Drug (IND) stages through to commercial production, ensuring regulatory compliance and optimizing drug efficacy and safety in Societal CDMO’s state-of-the-art facilities.

Scientific Research and Development

Leadership Team

Engineering

Scientific Research and Development

About

Team members

Other teams at Societal™ CDMO

Leadership Team

Engineering